Editorial: de novo inflammatory bowel disease following bariatric surgery-potential implications for research and clinical practice.

dc.contributor.authorAlukaidey, Sen
dc.contributor.authorHeerasing, Neelen
dc.date.accessioned2018-07-04T14:04:24Z
dc.date.available2018-07-04T14:04:24Z
dc.date.issued2018-06
dc.identifier.citationEditorial: de novo inflammatory bowel disease following bariatric surgery-potential implications for research and clinical practice. 2018, 47 (11):1539-1540 Aliment. Pharmacol. Ther.en
dc.identifier.doi10.1111/apt.14611
dc.identifier.issn1365-2036
dc.identifier.journalAlimentary pharmacology & therapeuticsen
dc.identifier.pmid29878431
dc.identifier.urihttp://hdl.handle.net/11287/620740
dc.language.isoenen
dc.publisherWileyen
dc.relation.urlhttp://dx.doi.org/10.1111/apt.14611en
dc.rightsArchived with thanks to Alimentary pharmacology & therapeuticsen
dc.subjectWessex Classification Subject Headings::Gastroenterologyen
dc.titleEditorial: de novo inflammatory bowel disease following bariatric surgery-potential implications for research and clinical practice.en
dc.typeEditorialen
dc.type.versionPublisheden
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.92 KB
Format:
Item-specific license agreed upon to submission
Description: